ARRY
Price
$8.97
Change
-$0.12 (-1.32%)
Updated
Sep 5 closing price
Capitalization
1.37B
59 days until earnings call
ETON
Price
$17.67
Change
-$0.20 (-1.12%)
Updated
Sep 5 closing price
Capitalization
473.87M
65 days until earnings call
Interact to see
Advertisement

ARRY vs ETON

Header iconARRY vs ETON Comparison
Open Charts ARRY vs ETONBanner chart's image
Array Technologies
Price$8.97
Change-$0.12 (-1.32%)
Volume$5.41M
Capitalization1.37B
Eton Pharmaceuticals
Price$17.67
Change-$0.20 (-1.12%)
Volume$286.78K
Capitalization473.87M
ARRY vs ETON Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. ETON commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and ETON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ARRY: $8.97 vs. ETON: $17.67)
Brand notoriety: ARRY and ETON are both not notable
ARRY represents the Alternative Power Generation, while ETON is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ARRY: 71% vs. ETON: 79%
Market capitalization -- ARRY: $1.37B vs. ETON: $473.87M
ARRY [@Alternative Power Generation] is valued at $1.37B. ETON’s [@Pharmaceuticals: Generic] market capitalization is $473.87M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $1.98B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileETON’s FA Score has 1 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • ETON’s FA Score: 1 green, 4 red.
According to our system of comparison, ETON is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while ETON’s TA Score has 6 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • ETON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ETON is a better buy in the short-term than ARRY.

Price Growth

ARRY (@Alternative Power Generation) experienced а -0.44% price change this week, while ETON (@Pharmaceuticals: Generic) price change was +2.08% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was +1.76%. For the same industry, the average monthly price growth was +11.41%, and the average quarterly price growth was +36.41%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ARRY is expected to report earnings on Nov 06, 2025.

ETON is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Alternative Power Generation (+1.76% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($1.37B) has a higher market cap than ETON($474M). ETON has higher P/E ratio than ARRY: ETON (124.00) vs ARRY (56.91). ARRY YTD gains are higher at: 48.510 vs. ETON (32.658). ETON has higher annual earnings (EBITDA): 1.84M vs. ARRY (-127.81M). ARRY has more cash in the bank: 377M vs. ETON (25.4M). ETON has less debt than ARRY: ETON (30.7M) vs ARRY (694M). ARRY has higher revenues than ETON: ARRY (1.17B) vs ETON (58.2M).
ARRYETONARRY / ETON
Capitalization1.37B474M289%
EBITDA-127.81M1.84M-6,931%
Gain YTD48.51032.658149%
P/E Ratio56.91124.0046%
Revenue1.17B58.2M2,012%
Total Cash377M25.4M1,484%
Total Debt694M30.7M2,261%
FUNDAMENTALS RATINGS
ARRY vs ETON: Fundamental Ratings
ARRY
ETON
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
10038
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
296
SEASONALITY SCORE
1..100
81n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ETON's Valuation (86) in the Pharmaceuticals Major industry is in the same range as ARRY (92) in the Biotechnology industry. This means that ETON’s stock grew similarly to ARRY’s over the last 12 months.

ETON's Profit vs Risk Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for ARRY (100) in the Biotechnology industry. This means that ETON’s stock grew somewhat faster than ARRY’s over the last 12 months.

ETON's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ETON’s stock grew similarly to ARRY’s over the last 12 months.

ETON's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as ARRY (37) in the Biotechnology industry. This means that ETON’s stock grew similarly to ARRY’s over the last 12 months.

ETON's P/E Growth Rating (6) in the Pharmaceuticals Major industry is in the same range as ARRY (29) in the Biotechnology industry. This means that ETON’s stock grew similarly to ARRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYETON
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 25 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPCIX31.320.14
+0.45%
Timothy Plan Israel Common Values C
MOGLX10.190.04
+0.39%
Gabelli Media Mogul
MCCRX17.390.03
+0.17%
MassMutual Small Cap Opps R3
OLVCX20.51N/A
N/A
JPMorgan Large Cap Value C
ITRGX69.86-0.25
-0.36%
VY® T. Rowe Price Growth Equity S2

ETON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-1.12%
MDGL - ETON
34%
Loosely correlated
+0.39%
VKTX - ETON
31%
Poorly correlated
+1.70%
LBTSF - ETON
30%
Poorly correlated
N/A
ARRY - ETON
30%
Poorly correlated
-1.32%
FDMT - ETON
29%
Poorly correlated
+9.98%
More